Skip to main content
Christiane Querfeld, MD, Dermatology, Duarte, CA, City of Hope Comprehensive Cancer Center

ChristianeQuerfeldMDPhD

Dermatology Duarte, CA

Dermatopathology

Professor; Dermatology/Dermatopathology; Director, Cutaneous Lymphoma Program

Dr. Querfeld is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Querfeld's full profile

Already have an account?

  • Office

    City of Hope National Medical Center
    1500 E Duarte Rd
    Duarte, CA 91010
    Phone+1 626-218-4052
    Fax+1 626-218-6190
  • Is this information wrong?

Education & Training

  • McGaw Medical Center of Northwestern University
    McGaw Medical Center of Northwestern UniversityFellowship, Dermatopathology, 2010 - 2011
  • University of Chicago
    University of ChicagoResidency, Dermatology, 2007 - 2010
  • Good Samaritan Hospital of Maryland
    Good Samaritan Hospital of MarylandInternship, Internal Medicine, 2006 - 2007
  • McGaw Medical Center of Northwestern University
    McGaw Medical Center of Northwestern UniversityResidency, Dermatology, 2002 - 2004
  • University of Heidelberg
    University of HeidelbergPhD, Microbiology/Immunology, 1995
  • Univ Cologne- Fac Med
    Univ Cologne- Fac MedClass of 1994

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2014 - 2025
  • NY State Medical License
    NY State Medical License 2011 - 2016
  • IL State Medical License
    IL State Medical License 2010 - 2014
  • American Board of Dermatology Dermatology
  • American Board of Dermatology Dermatopathology

Awards, Honors, & Recognition

  • Scholar in Clinical Research Leukemia Lymphoma Society, 2018
  • Excellence Award City of Hope, 2017
  • Junior Investigator Research Development Award City of Hope, 2016
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Lectures

  • Bnz-1, a Selective _-Chain Cytokine Inhibitor Has Clinical Activity in Patients with Cutaneous T Cell Lymphoma By Selectively Blocking IL-2, IL-15 and IL-9 Signaling: ... 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
  • Phase 1 Results of Anti-PD-Ligand 1 (Durvalumab) & Lenalidomide in Patients with Cutaneous T Cell Lymphoma and Correlation with Programmed Death Ligand 1 Expression an... 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
  • Intralesional Administration of the CD47 Antagonist TTI-621 (SIRPαFc) Induces Responses in Both Injected and Non-Injected Lesions in Patients with Relapsed/Refractory ... 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Press Mentions

  • A Study Associates the Use of Hydroquinone with the Risk of Skin Cancer -News Forest
    A Study Associates the Use of Hydroquinone with the Risk of Skin Cancer -News ForestAugust 26th, 2022
  • Regional Lymph Nodes Guarded by Immune Cells
    Regional Lymph Nodes Guarded by Immune CellsOctober 4th, 2021
  • City of Hope Awarded $7.5 Million to Develop Better Treatment for a Rare, Incurable Cancer
    City of Hope Awarded $7.5 Million to Develop Better Treatment for a Rare, Incurable CancerMarch 21st, 2019
  • Join now to see all

Professional Memberships

Other Languages

  • German

Hospital Affiliations